Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy
The goal of this research study is to learn more about the safety of treating NSCLC with reirradiation using standard methods and to look for ways to lessen side effects and improve therapy. Reirradiation is when radiation is given to an area of the body that has previously received a full dose of radiation.
Checked against the public recordLast updated Aug 24, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- M.D. Anderson Cancer Center
- Interventions being studied
- Other: Thoracic Reirradiation Registry
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. History of previous histologically or cytologically documented NSCLC, stage I-IV. 2. Prior course of radiation therapy or concurrent chemoradiation at least 1 month prior to the current course of radiation therapy. 3. Patients eligible to receive a second course of radiation therapy to the thorax, at the discretion of the treating physician. 4. Patients receiving concurrent chemotherapy or targeted agents will be eligible for this protocol. 3.2 Exclusion Criteria: 1. Life expectancy\<3 months 2. Pregnancy.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Texas MD Anderson Cancer CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 24, 2016. Always confirm current availability with the study team.